Illumina Body Map 2
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_+_42423872 Show fit | 2.13 |
ENST00000230882.4
ENST00000357703.3 |
growth hormone receptor |
|
| chr16_+_56672571 Show fit | 1.60 |
ENST00000290705.8
|
metallothionein 1A |
|
| chr11_+_113930291 Show fit | 1.33 |
ENST00000335953.4
|
zinc finger and BTB domain containing 16 |
|
| chr7_-_95225768 Show fit | 1.22 |
ENST00000005178.5
|
pyruvate dehydrogenase kinase, isozyme 4 |
|
| chr11_+_12695944 Show fit | 1.21 |
ENST00000361905.4
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
|
| chr6_+_43737939 Show fit | 1.17 |
ENST00000372067.3
|
vascular endothelial growth factor A |
|
| chr12_+_109554386 Show fit | 1.12 |
ENST00000338432.7
|
acetyl-CoA carboxylase beta |
|
| chr8_-_75233563 Show fit | 1.02 |
ENST00000342232.4
|
junctophilin 1 |
|
| chr18_-_30050395 Show fit | 1.02 |
ENST00000269209.6
ENST00000399218.4 |
GRB2 associated, regulator of MAPK1 |
|
| chr11_+_94501497 Show fit | 1.01 |
ENST00000317829.8
ENST00000317837.9 ENST00000433060.2 |
angiomotin like 1 |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 2.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 1.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 1.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 | 1.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 | 1.3 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
| 0.0 | 1.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.4 | 1.2 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.1 | 1.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.0 | 1.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.4 | 1.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.0 | 3.1 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.7 | 2.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.0 | 2.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 2.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.3 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 1.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 1.1 | GO:0031941 | filamentous actin(GO:0031941) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 2.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 2.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 2.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 1.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.0 | 1.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 1.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.0 | 1.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.0 | 2.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 2.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 2.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 1.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 1.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |